Mitochondria-targeted alginate/triphenylphosphonium-grafted-chitosan for treatment of hepatocellular carcinoma
Open Access
- 4 August 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (34) , 21690-21703
Abstract
Mitochondrial targeting of anticancer drugs can effectively eradicate tumour cells. TPP+-grafted-chitosan based core–shell nanoparticles were successfully internalized into the mitochondria of HCC cells. Also exhibited antiproliferative activity against liver cancer.Keywords
Funding Information
- Academy of Scientific Research and Technology (JESOR)
This publication has 38 references indexed in Scilit:
- Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeuticsProceedings of the National Academy of Sciences, 2012
- Mitochondria-Targeted Small Molecule Therapeutics and ProbesAntioxidants & Redox Signaling, 2011
- Novel water soluble phosphonium chitosan derivatives: Synthesis, characterization and cytotoxicity studiesInternational Journal of Biological Macromolecules, 2011
- Subcellular targeting strategies for drug design and deliveryNature Reviews Drug Discovery, 2010
- Cardiomyocyte death in doxorubicin-induced cardiotoxicityArchivum Immunologiae et Therapiae Experimentalis, 2009
- Study on the potential anti-cancer activity of phosphonium and ammonium-based ionic liquidsBioorganic & Medicinal Chemistry Letters, 2009
- Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†Hepatology, 2008
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences, 2006
- Mitochondriotropic LiposomesJournal of Liposome Research, 2005
- Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological ModelCritical Reviews in Toxicology, 2003